GlassScriptPhysician profile
Nancy L Phillips
NPI 1750459103
$2,245.89
in general payments reported to CMS, 2019-2025
14 companies · $210 in 2025
The $210 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $264 · 2021: $312 · 2022: $423 · 2023: $380 · 2024: $410 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $552.57 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $415.68 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Ironshore Pharmaceuticals INC. | $321.10 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $298.60 | 2019-2023 | Dyanavel Xr |
| Sanofi Pasteur INC. | $176.39 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.98 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $86.78 | 2021-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Neos Therapeutics, LP | $84.67 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $77.62 | 2021-2022 | |
| Kaleo, INC. | $42.84 | 2020-2022 | |
| Shire North American Group INC | $30.32 | 2019 | |
| Pfizer INC. | $19.40 | 2023 | |
| Pharming Healthcare, INC. | $19.02 | 2025 | Ruconest |
| Sanofi-Aventis U.S. LLC | $16.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.